Demand for Substance Abuse Treatment Related to Use of Crystal Methamphetamine in Ontario: an Observational Study

被引:2
|
作者
Brands, Bruna [1 ,2 ,3 ]
Corea, Larry [2 ]
Strike, Carol [2 ,4 ]
Singh, Veeran-Anne S. [1 ]
Behrooz, Renee C. [2 ]
Rush, Brian [2 ,4 ,5 ]
机构
[1] Hlth Canada, Off Res & Surveillance, Controlled Subst & Tobacco Directorate, Ottawa, ON K1A 0K9, Canada
[2] Ctr Addict & Mental Hlth, Toronto, ON, Canada
[3] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[4] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[5] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
关键词
Methamphetamine; Substance abuse treatment; Treatment admissions; ALCOHOL; SYSTEMS;
D O I
10.1007/s11469-011-9362-1
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Concerns about methamphetamine/crystal methamphetamine (MA) have featured prominently in the Canadian media and on addiction treatment agency agendas. We examined MA admissions at addiction treatment agencies to determine if a service gap existed. In 2006, all addiction treatment agencies (n=124) in Ontario, Canada were invited to complete an on-line survey. The provincial database provided admissions data for 2006-2008. Amongst participants (n=100), 53% reported an increase in clients with MA problems between 2004 and 2005. Nine percent considered MA to be a significant problem and 60% indicated that MA was a minor problem or not a problem in 2005. Forty-seven percent of participants said that MA problems were more common among males and 60% of MA clients were aged 16-24. Most (89%) agencies integrated MA clients into regular programs and 73% had not considered developing specialized MA programs. MA admissions peaked at 2.4% of admissions in 2005 and dropped to a lower, stable percent (2006-2008). Media and public alarm about a MA 'epidemic' is not consistent with admissions data or agency experience. Consideration of objective evidence before demands for additional resources is necessary.
引用
收藏
页码:696 / 709
页数:14
相关论文
共 50 条
  • [1] Demand for Substance Abuse Treatment Related to Use of Crystal Methamphetamine in Ontario: an Observational Study
    Bruna Brands
    Larry Corea
    Carol Strike
    Veeran-Anne S. Singh
    Renée C. Behrooz
    Brian Rush
    International Journal of Mental Health and Addiction, 2012, 10 : 696 - 709
  • [2] A multisite study of the effectiveness of methamphetamine treatment: An initiative of the center for substance abuse treatment
    Herrell, JM
    Taylor, JA
    Gallagher, C
    Dawud-Noursi, S
    JOURNAL OF PSYCHOACTIVE DRUGS, 2000, 32 (02) : 143 - 147
  • [3] Substance abuse treatment for Ontario residents in the United States
    Rush, B
    Tyas, S
    Martin, G
    ADDICTION, 1996, 91 (05) : 671 - 685
  • [4] Substance Abuse Treatment for Adolescents: How are Family Factors Related to Substance Use Change?
    Bertrand, Karine
    Richer, Isabelle
    Brunelle, Natacha
    Beaudoin, Isabelle
    Lemieux, Annie
    Menard, Jean-Marc
    JOURNAL OF PSYCHOACTIVE DRUGS, 2013, 45 (01) : 28 - 38
  • [5] Demand characteristics of residential substance abuse treatment programs
    Timko, C
    Yu, K
    Moos, RH
    JOURNAL OF SUBSTANCE ABUSE, 2000, 12 (04) : 387 - 403
  • [6] HARM REDUCTION SUBSTANCE ABUSE TREATMENT WITH METHAMPHETAMINE-USING MSM
    Carrico, Adam W.
    Siever, Michael D.
    Michael, Discepola V.
    Woods, William J.
    ANNALS OF BEHAVIORAL MEDICINE, 2013, 45 : S65 - S65
  • [7] Use ecology and drug use motivations of methamphetamine users admitted to substance abuse treatment facilities in Los Angeles: An emerging profile
    von Mayrhauser, C
    Brecht, ML
    Anglin, MD
    JOURNAL OF ADDICTIVE DISEASES, 2002, 21 (01) : 45 - 60
  • [8] Gender and use of substance abuse treatment services
    Green, CA
    ALCOHOL RESEARCH & HEALTH, 2006, 29 (01) : 55 - 62
  • [9] USE OF YOGA AS A THERAPY FOR SUBSTANCE ABUSE TREATMENT
    Srinivasa, S. R.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 41 : 363A - 363A
  • [10] SUBSTANCE USE ABUSE CONCEPTUALIZATION, ETIOLOGY AND TREATMENT
    HENDERSON, JH
    JOURNAL OF DRUG ISSUES, 1982, 12 (04) : 317 - 332